Literature DB >> 1110975

Tests of two electron-affinic radiosensitizers in vivo using regrowth of an experimental carcinoma.

J Denekamp, S R Harris.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1110975

Source DB:  PubMed          Journal:  Radiat Res        ISSN: 0033-7587            Impact factor:   2.841


× No keyword cloud information.
  22 in total

Review 1.  Tumor hypoxia: its impact on cancer therapy.

Authors:  J E Moulder; S Rockwell
Journal:  Cancer Metastasis Rev       Date:  1987       Impact factor: 9.264

Review 2.  Can dose-survival parameters be deduced from in situ assays?

Authors:  T E Wheldon
Journal:  Br J Cancer Suppl       Date:  1980-04

Review 3.  Is any single in situ assay of tumour response adequate?

Authors:  J Denekamp
Journal:  Br J Cancer Suppl       Date:  1980-04

4.  Toxic and radiosensitizing effect of the 2-nitroimidazole misonidazole (Ro-07-0582) on murine CFU in vivo.

Authors:  E O Pettersen
Journal:  Br J Cancer Suppl       Date:  1978-06

Review 5.  Assessing the bioreductive effectiveness of the nitroimidazole RSU1069 and its prodrug RB6145: with particular reference to in vivo methods of evaluation.

Authors:  J C Bremner
Journal:  Cancer Metastasis Rev       Date:  1993-06       Impact factor: 9.264

6.  Radiobiological studies of tumours in situ compared with cell survival.

Authors:  N J McNally; J de Ronde
Journal:  Br J Cancer Suppl       Date:  1980-04

7.  Conversion of xanthine dehydrogenase to xanthine oxidase as a possible marker for hypoxia in tumours and normal tissues.

Authors:  R F Anderson; K B Patel; K Reghebi; S A Hill
Journal:  Br J Cancer       Date:  1989-08       Impact factor: 7.640

8.  Flurbiprofen, a non-steroid anti-inflammatory agent, protects cells against hypoxic cell radiosensitizers in vitro.

Authors:  B C Millar; S Jinks; T J Powles
Journal:  Br J Cancer       Date:  1981-11       Impact factor: 7.640

9.  Radiation and nitroimidazoles in supratentorial high grade gliomas: a second clinical trial.

Authors:  R Urtasun; M L Feldstein; J Partington; H Tanasichuk; J D Miller; D B Russell; O Agboola; B Mielke
Journal:  Br J Cancer       Date:  1982-07       Impact factor: 7.640

10.  Is tumour radiosensitization by misonidazole a general phenomenon?

Authors:  J Denekamp; D G Hirst; F A Stewart; N H Terry
Journal:  Br J Cancer       Date:  1980-01       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.